Tag: GEJ adenocarcinoma

#VisualAbstract: Perioperative pembrolizumab with chemotherapy for gastric and gastroesophageal junction adenocarcinoma improves pathological complete response rate compared with placebo

byAlisha Yiand1 others

January 11, 2024

1. The median overall survival and event-free survival were not statistically different in the pembrolizumab group as compared to the ...

Equivalent efficacy of Paclitaxel or Irinotecan for advanced gastric cancer

Perioperative pembrolizumab with chemotherapy for gastric and gastroesophageal junction adenocarcinoma improves pathological complete response rate compared with placebo

byKassandra McFarlaneand1 others

January 8, 2024

1. The median overall survival and event-free survival were not statistically different in the pembrolizumab group as compared to the ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: GEJ adenocarcinoma

#VisualAbstract: Perioperative pembrolizumab with chemotherapy for gastric and gastroesophageal junction adenocarcinoma improves pathological complete response rate compared with placebo

Perioperative pembrolizumab with chemotherapy for gastric and gastroesophageal junction adenocarcinoma improves pathological complete response rate compared with placebo

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports